Table of Contents
Leukemia Research and Treatment
Volume 2016 (2016), Article ID 1675326, 6 pages
http://dx.doi.org/10.1155/2016/1675326
Research Article

Human T-Cell Lymphotropic Virus Types 1 and 2 Seropositivity among Blood Donors at Mbarara Regional Blood Bank, South Western Uganda

1Department of Microbiology, Faculty of Medicine, Mbarara University Science & Technology, P.O. Box 1410, Mbarara, Uganda
2Department of Medical Laboratory Science, Faculty of Medicine, Mbarara University of Science & Technology, P.O. Box 1410, Mbarara, Uganda

Received 14 October 2015; Revised 5 January 2016; Accepted 13 January 2016

Academic Editor: Daniela Cilloni

Copyright © 2016 Patience Uchenna Tweteise et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Sertöz, A. Turhan, H. Bozkurt et al., “Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey,” Mikrobiyoloji Bülteni, vol. 44, no. 4, pp. 579–584, 2010. View at Google Scholar · View at Scopus
  2. F. A. Proietti, A. B. F. Carneiro-Proietti, B. C. Catalan-Soares, and E. L. Murphy, “Global epidemiology of HTLV-I infection and associated diseases,” Oncogene, vol. 24, no. 39, pp. 6058–6068, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Gessain and O. Cassar, “Epidemiological aspects and world distribution of HTLV-1 infection,” Frontiers in Microbiology, vol. 3, article 388, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Shindo, L. C. J. Alcantara, S. Van Dooren et al., “Human retroviruses (HIV and HTLV) in Brazilian Indians: seroepidemiological study and molecular epidemiology of HTLV type 2 isolates,” AIDS Research and Human Retroviruses, vol. 18, no. 1, pp. 71–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. D. F. Roucoux and E. L. Murphy, “The epidemiology and disease outcomes of human T-lymphotropic virus type II,” AIDS Reviews, vol. 6, no. 3, pp. 144–154, 2004. View at Google Scholar · View at Scopus
  6. M. S. S. Namen-Lopes, M. L. Martins, P. C. Drummond, R. R. Lobato, and A. B. F. Carneiro-Proietti, “Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil,” Transfusion Medicine, vol. 19, no. 4, pp. 180–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Tsuji, H. Doi, T. Yamabe, T. Ishimaru, T. Miyamoto, and S. Hino, “Prevention of mother-to-child transmission of human T-lymphotropic virus type-I,” Pediatrics, vol. 86, no. 1, pp. 11–17, 1990. View at Google Scholar · View at Scopus
  8. H. H. Lee, S. H. Weiss, L. S. Brown et al., “Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA,” Journal of Infectious Diseases, vol. 162, no. 2, pp. 347–352, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. D. F. Roucoux, B. Wang, D. Smith et al., “A prospective study of sexual transmission of human T lymphotropic virus (HTLV)–I and HTLV-II,” The Journal of Infectious Diseases, vol. 191, no. 9, pp. 1490–1497, 2005. View at Publisher · View at Google Scholar
  10. M. L. Martins, R. G. Andrade, B. H. Nédir, and E. F. Barbosa-Stancioli, “Human T-lymphotropic viruses (HTLV),” in Blood Transfusion in Clinical Practice, P. K. Kochhar, Ed., chapter 10, InTech, Rijeka, Croatia, 2012. View at Publisher · View at Google Scholar
  11. A. Manns, R. J. Wilks, E. L. Murphy et al., “A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion,” International Journal of Cancer, vol. 51, no. 6, pp. 886–891, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Catalan-Soares, A. B. Carneiro-Proietti, and F. A. Proietti, “Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil,” Cadernos de Saúde Pública, vol. 21, no. 3, pp. 926–931, 2005. View at Google Scholar
  13. S. Inaba, H. Sato, K. Okochi et al., “Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience,” Transfusion, vol. 29, no. 1, pp. 7–11, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. Centers for Disease Control, “Human T-lymphotropic virus type I screening in volunteer blood donors—United States, 1989,” Morbidity and Mortality Weekly Report, vol. 39, no. 915, pp. 921–924, 1990. View at Google Scholar
  15. A.-M. Couroucé, J. Pillonel, J.-M. Lemaire, and C. Saura, “HTLV testing in blood transfusion,” Vox Sanguinis, vol. 74, no. 2, pp. 165–169, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. C. R. Seed, P. Kiely, and A. J. Keller, “Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus,” Internal Medicine Journal, vol. 35, no. 10, pp. 592–598, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Tynell, S. Andersson, E. Lithander et al., “Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis,” British Medical Journal, vol. 316, pp. 1417–1422, 1998. View at Publisher · View at Google Scholar
  18. S. A. Glynn, S. H. Kleinman, and G. B. Schreiber, “Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS),” Journal of the American Medical Association, vol. 284, no. 2, pp. 229–235, 2000. View at Publisher · View at Google Scholar
  19. L. Kish, Survey Sampling, John Wiley & Sons, New York, NY, USA, 1965.
  20. F. Sarkodie, M. Adarkwa, Y. Adu-Sarkodie, D. Candotti, J. W. Acheampong, and J. P. Allain, “Screening for viral markers in volunteer and replacement blood donors in West Africa,” Vox Sanguinis, vol. 80, no. 3, pp. 142–147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. E. S. Gudo, C. M. Abreu, T. Mussá et al., “Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique,” Mozambique. Transfusion, vol. 49, no. 6, pp. 1146–1150, 2009. View at Publisher · View at Google Scholar
  22. O. A. T. Alli, O. D. Olusoga, A. S. Oluremi, B. M. Okanlawon, L. N. Uche, and F. A. Muibi, “Seroprevalence of HTLV-I/II amongst blood donors in Osogbo, Nigeria,” Sudan Journal of Medical Sciences, vol. 6, no. 3, pp. 177–182, 2011. View at Google Scholar
  23. W. M. G. de Lima, F. A. M. Esteves, M. D. C. M. R. Torres, and E. S. F. Pires, “Prevalence of human T-cell lymphotropic virus types 1 and 2 in blood donors of the Caruaru Blood Center (Hemope),” Revista Brasileira de Hematologia e Hemoterapia, vol. 35, no. 4, pp. 268–271, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Y. Le Hesran, E. Delaporte, C. Gaudebout et al., “Demographic factors associated with HTLV-1 infection in a Gabonese community,” International Journal of Epidemiology, vol. 23, no. 4, pp. 812–817, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Caterino-de-Araujo, M. C. Magri, E. A. S. Costa, and R. C. R. Manuel, “Prevalence of human T-Cell lymphotropic virus (HTLV-1/2) in individuals from public health centers in Mozambique,” AIDS Research and Human Retroviruses, vol. 26, no. 5, pp. 559–561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Blas, F. Bravo, W. Castillo et al., “Norwegian scabies in Peru: the impact of human T cell lymphotropic virus type I infection,” The American Journal of Tropical Medicine and Hygiene, vol. 72, no. 6, pp. 855–857, 2005. View at Google Scholar · View at Scopus
  27. M. Amano, M. Setoyama, A. Grant, and F. A. Kerdel, “Human T-lymphotropic virus 1 (HTLV-1) infection–dermatological implications,” International Journal of Dermatology, vol. 50, no. 8, pp. 915–920, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. B. Carneiro-Proietti, E. C. Sabino, S. Leão et al., “Human T lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007–2009,” AIDS Research and Human Retroviruses, vol. 28, no. 10, pp. 1265–1272, 2012. View at Google Scholar